CD4 and lung adenocarcinoma: In this study, our results showed low levels of B cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells were associated with poor prognosis of lung adenocarcinoma patients, while high ALDOA expression was correlated with poor prognosis in lung adenocarcinoma patients.